Exane BNP Paribas upgraded Auto1 Group (ATOGF) to Outperform from Neutral with a EUR 30 price target The firm cites momentum in the company’s ...

Exane BNP Paribas downgraded Valeo (VLEEY) to Neutral from Outperform with a EUR 10.50 price target The firm prefers shares of Forvia over ...

Fintel reports that on March 12, 2025, Exane BNP Paribas upgraded their outlook for Medical Properties Trust (NYSE:MPW) from ...

On Friday, BNP Paribas (OTC:BNPQY) Exane analyst Mourad Lahmidi upgraded AUTO1 Group SE (AG1:GR) (OTC: ATOGF) stock rating from Neutral to Outperform, setting a new price target at €30.00 ...

On Thursday, BNP Paribas (OTC:BNPQY) Exane analyst Stephen Benhamou downgraded Valeo SA (FR:FP) (OTC: OTC:VLEEY) stock rating from Outperform to Neutral and adjusted the price target to €10.50. The $2 ...

BNP Paribas’ THEAM Quant platform, in collaboration with BNP Paribas Exane Research, has launched the THEAM Quant – Nuclear ...

“Last September, equity markets were at relative lows and recession in Europe seemed inevitable,” said Theepan Jothilingam, head of EMEA research at BNP Paribas Exane. “Talk of a recession ...

Fintel reports that on March 12, 2025, Exane BNP Paribas upgraded their outlook for Medical Properties Trust (LSE:0JZZ) from Neutral to Outperform. As of March 3, 2025, the average one-year price ...

On Friday, BNP Paribas (OTC:BNPQY) Exane analyst Mourad Lahmidi upgraded AUTO1 Group SE (AG1:GR) (OTC: ATOGF) stock rating from Neutral to Outperform, setting a new price target at €30.00, a ...